Hunan Hansen Pharmaceutical Co Ltd Class A 002412
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 6.00
- Day Range
- CNY 5.97–6.09
- 52-Week Range
- CNY 4.08–7.38
- Bid/Ask
- CNY 6.00 / CNY 6.01
- Market Cap
- CNY 3.01 Bil
- Volume/Avg
- 6.8 Mil / 11.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 14.33
- Price/Sales
- 3.15
- Dividend Yield (Trailing)
- 5.00%
- Dividend Yield (Forward)
- 5.00%
- Total Yield
- 5.00%
Company Profile
Hunan Hansen Pharmaceutical Co Ltd is producing Chinese and Western medicines. Its main dosage forms include large-volume injections, small-volume injections, oral liquids, tablets, hard capsules, granules, syrups, ointments, tinctures, and pills. The company's main products are Si Mo Tang Oral Liquid, Shuanquan Capsule, Ginkgo Biloba Capsule and Tianma Xingnao Capsule.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,536
- Website
- http://www.hansenzy.com
Comparables
Valuation
|
Metric
|
002412
|
603998
|
603963
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.33 | 40.07 | — |
Price/Book Value | 1.49 | 3.55 | 3.14 |
Price/Sales | 3.15 | 3.40 | 18.18 |
Price/Cash Flow | 27.20 | 27.92 | — |
Price/Earnings
002412
603998
603963
Financial Strength
|
Metric
|
002412
|
603998
|
603963
|
|---|---|---|---|
Quick Ratio | 1.96 | 0.56 | 3.10 |
Current Ratio | 2.77 | 1.00 | 3.98 |
Interest Coverage | 65.08 | 13.06 | −13.31 |
Quick Ratio
002412
603998
603963
Profitability
|
Metric
|
002412
|
603998
|
603963
|
|---|---|---|---|
Return on Assets (Normalized) | 9.05% | 5.35% | −6.09% |
Return on Equity (Normalized) | 10.91% | 11.14% | −7.42% |
Return on Invested Capital (Normalized) | 10.42% | 8.19% | −6.63% |
Return on Assets
002412
603998
603963
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Dwvlyjvfzw | Xznvwg | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Gskgjgrn | Ftyfx | $79.3 Bil | |
HLN
| Haleon PLC ADR | Cprctmlx | Fzwv | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vqwywtc | Frh | $18.9 Bil | |
VTRS
| Viatris Inc | Nbyxggq | Gffxg | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qkhzczhz | Hhd | $11.7 Bil | |
CTLT
| Catalent Inc | Sppjjzjm | Gjbdnk | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Xxqwwsv | Nnphk | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Vdwkbtqr | Sfcn | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fqdvyvqpv | Whdqhy | $3.2 Bil |